Thiourea

Thiourea

SCHEMBL2584115

COc1ccc(N2CCN(c3ccc(OC)cc3)C2=S)cc1.NC(N)=S

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.49
NPSR1 Q6W5P4 1/20 0.46
L3MBTL1 Q9Y468 3/20 0.45
TP53 P04637 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TAAR1 Q96RJ0 1/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
MAPT P10636 1/20 0.44
MAOB P27338 1/20 0.43
LMNA P02545 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HTR3E A5X5Y0 1/20 0.42
HTR3B O95264 1/20 0.42
ADRB1 P08588 1/20 0.42
HTR3A P46098 1/20 0.42
HTR3D Q70Z44 1/20 0.42
HTR3C Q8WXA8 1/20 0.42
SIGMAR1 Q99720 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2579648 0.91 HTR3E (0.48) POLBNPSR1L3MBTL1TP53SMN1; SMN2
Hydrochloric Acid SCHEMBL2579274 0.87 GAA (0.46) POLBNPSR1L3MBTL1TP53SMN1; SMN2
SCHEMBL16789887 0.75 HTR3E (0.52) POLBL3MBTL1SMN1; SMN2ALDH1A1MAPT
SCHEMBL4081119 0.75 POLB (0.68) POLBL3MBTL1SMN1; SMN2TAAR1ALDH1A1
SCHEMBL4631544 0.75 POLB (0.68) POLBL3MBTL1SMN1; SMN2TAAR1ALDH1A1
Trifluoromethanesulfonic Acid SCHEMBL2584928 0.74 NOX4 (0.50) SMN1; SMN2LMNA
SCHEMBL11178945 0.72 SIGMAR1 (0.54) POLBL3MBTL1ALDH1A1MAPTKMT2A
SCHEMBL15328020 0.71 HDAC1 (0.48) POLBL3MBTL1SMN1; SMN2ALDH1A1MAPT
SCHEMBL16786533 0.69 ACHE (0.58) POLBSMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL26186618 0.69 POLB (0.69) POLBL3MBTL1SMN1; SMN2TAAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722897-B2 Metal complexes of thiourea and derivatives as metal delivering anti-cancer and anti-inflammatory agents GOLDPORP PHARMA LIMITED (CN) 2014-05-13 US disclosed
WO-2011134275-A1 METAL COMPLEXES OF THIOUREA AND THEIR DERIVATIVES AS METAL DELIVERING ANTI-CANCER AND ANTI-INFLAMMATORY AGENTS CHE CHI-MING (CN) 2011-11-03 WO disclosed
US-20110269730-A1 Metal Complexes of Thiourea and Derivatives as Metal Delivering Anti-Cancer and Anti-Inflammatory Agents GOLDPORP PHARMA LIMITED (CN) 2011-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269730-A1 Metal Complexes of Thiourea and Derivatives as Metal Delivering Anti-Cancer and Anti-Inflammatory Agents CLIC1, SLC30A5, TIA1 POLB 2379/4885NPSR1 3711/4885L3MBTL1 307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.